Efficacy and Prognostic Factors of Combined Hyperbaric Oxygen Therapy in Patients With Idiopathic Sudden Sensorineural Hearing Loss | Canada Hyperbarics Skip to main content
Study Am J Audiol 2019

Efficacy and Prognostic Factors of Combined Hyperbaric Oxygen Therapy in Patients With Idiopathic Sudden Sensorineural Hearing Loss

Wang Y, Gao Y, Wang B, Chen L, Zhang X — Am J Audiol, 2019

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers retrospectively analyzed 64 patients with idiopathic sudden sensorineural hearing loss treated with HBOT plus drug therapies, investigating clinical predictors of hearing recovery including age, hearing curve type, and timing of treatment.

What They Found

The total effective rate was 59.37%, including 25% complete recovery. Starting HBOT within 7 days of onset was the strongest independent predictor of recovery (OR = 27.8, 95% CI 4.2 to 183.1, p = 0.001). Even patients with complete deafness showed 57% recovery when treated early.

What This Means for Canadian Patients

Sudden hearing loss is a medical emergency where treatment timing is critical. Canadian ENT specialists should know that initiating HBOT within 7 days of sudden hearing loss dramatically improves the chance of recovery -- particularly in patients with complete hearing loss who have the most to gain.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective study of 64 patients at a single center; the wide confidence interval on the early-treatment odds ratio suggests uncertainty, and larger prospective trials are needed.

Was this summary helpful?

Study Details

Study Type Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 30938564
Year Published 2019
Journal Am J Audiol
MeSH Terms Adult; Aged; Aged, 80 and over; Audiometry, Pure-Tone; Combined Modality Therapy; Female; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Time-to-Treatment; Treatment Outcome; Vasodilator Agents

Cite This Study

Share

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.